NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free AVNS Stock Alerts $19.91 +0.01 (+0.05%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$19.86▼$20.1350-Day Range$18.43▼$19.9152-Week Range$17.24▼$31.31Volume232,956 shsAverage Volume242,920 shsMarket Capitalization$919.84 millionP/E RatioN/ADividend YieldN/APrice Target$31.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Avanos Medical alerts: Email Address Avanos Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside55.7% Upside$31.00 Price TargetShort InterestBearish2.97% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$152,960 Sold Last QuarterProj. Earnings Growth33.33%From $1.38 to $1.84 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.19 out of 5 starsMedical Sector378th out of 938 stocksSurgical Appliances & Supplies Industry9th out of 16 stocks 3.3 Analyst's Opinion Consensus RatingAvanos Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $31.00, Avanos Medical has a forecasted upside of 55.7% from its current price of $19.91.Amount of Analyst CoverageAvanos Medical has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.97% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Avanos Medical has recently increased by 6.35%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 1.1 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Avanos Medical this week, compared to 3 articles on an average week.Search Interest2 people have searched for AVNS on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have sold 1,441.16% more of their company's stock than they have bought. Specifically, they have bought $9,925.00 in company stock and sold $152,960.00 in company stock.Percentage Held by InsidersOnly 2.90% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 33.33% in the coming year, from $1.38 to $1.84 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -15.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -15.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAvanos Medical has a PEG Ratio of 1.14. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy About Avanos Medical Stock (NYSE:AVNS)Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More AVNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVNS Stock News HeadlinesMarch 16, 2024 | insidertrades.comAvanos Medical, Inc. (NYSE:AVNS) CFO Michael Greiner Sells 8,000 SharesMarch 20, 2024 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Upgraded to Buy by StockNews.comMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.February 22, 2024 | finance.yahoo.comAvanos Medical Full Year 2023 Earnings: US$0.21 loss per share (vs US$1.08 profit in FY 2022)February 22, 2024 | markets.businessinsider.comAvanos Medical Issues Voluntary Recall Amid Nurse Assist Sterile Water Product RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | prnewswire.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.February 20, 2024 | msn.comSupplementary Review: Avanos Medical (AVNS), February 20, 2024February 20, 2024 | seekingalpha.comAvanos Medical, Inc. 2023 Q4 - Results - Earnings Call PresentationFebruary 20, 2024 | msn.comAvanos Medical reports mixed Q4 results; initiates FY24 outlookFebruary 20, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 20, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Reports Mixed 2023 Financial Results Amid Transformation InitiativeFebruary 20, 2024 | prnewswire.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 17, 2024 | finance.yahoo.comAVNS Mar 2024 20.000 callFebruary 16, 2024 | msn.comAvanos Medical Q4 2023 Earnings PreviewFebruary 15, 2024 | finance.yahoo.comAvanos Medical, Inc. (AVNS)February 14, 2024 | markets.businessinsider.comAnalysts Are Neutral on These Healthcare Stocks: Avanos Medical (AVNS), Incyte (INCY)February 14, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial ResultsJanuary 22, 2024 | finance.yahoo.comNew Strong Sell Stocks for January 9thJanuary 22, 2024 | finance.yahoo.comNew Strong Sell Stocks for January 12thJanuary 22, 2024 | finance.yahoo.comNew Strong Sell Stocks for January 16thJanuary 5, 2024 | benzinga.comAvanos Medical Stock (NYSE:AVNS), Short Interest ReportJanuary 5, 2024 | finance.yahoo.comAvanos (AVNS) Preliminary Q4 Revenues Dampened by Lower SalesJanuary 5, 2024 | benzinga.comAvanos Medical Stock (NYSE:AVNS) Dividends: History, Yield and DatesJanuary 4, 2024 | marketwatch.comAvanos Medical Warns of 4Q, 2024 Sales ShortfallsSee More Headlines Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today3/29/2024Next Earnings (Estimated)5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees3,771Year FoundedN/APrice Target and Rating Average Stock Price Target$31.00 High Stock Price Target$31.00 Low Stock Price Target$31.00 Potential Upside/Downside+55.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.32) Trailing P/E RatioN/A Forward P/E Ratio14.43 P/E Growth1.14Net Income$-61,800,000.00 Net Margins-8.76% Pretax Margin-1.17% Return on Equity4.25% Return on Assets3.11% Debt Debt-to-Equity Ratio0.13 Current Ratio2.08 Quick Ratio1.38 Sales & Book Value Annual Sales$673.30 million Price / Sales1.37 Cash Flow$2.05 per share Price / Cash Flow9.69 Book Value$26.63 per share Price / Book0.75Miscellaneous Outstanding Shares46,200,000Free Float44,863,000Market Cap$919.84 million OptionableOptionable Beta0.95 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Joseph F. Woody (Age 58)CEO & Director Comp: $2.37MMr. Michael C. Greiner (Age 51)Senior VP, CFO & Chief Transformation Officer Comp: $940.45kMs. Mojirade James (Age 57)Senior VP, General Counsel & Corporate Secretary Comp: $759.53kMr. Kerr W. Holbrook (Age 56)Senior VP, GM of Chronic Care & Chief Commercial Officer Comp: $716.87kMr. John Joseph HurleyPrincipal Accounting Officer & ControllerMr. David CrawfordVP of FP&A and Investor Relations and TreasurerMs. Michelle ScharfenbergSenior VP and Chief Ethics & Compliance OfficerMr. Scott GalovanVice President of Strategy & Corporate DevelopmentJohn W. CatoVice President of Human ResourcesMr. Lee BurnesSenior Vice President of Global R&D, Clinical and Medical AffairsMore ExecutivesKey CompetitorsJin Medical InternationalNASDAQ:ZJYLEstablishment LabsNASDAQ:ESTASanara MedTechNASDAQ:SMTIEnovisNYSE:ENOVORIC PharmaceuticalsNASDAQ:ORICView All CompetitorsInsiders & InstitutionsQuadrature Capital LtdBought 9,320 shares on 3/25/2024Ownership: 0.050%PNC Financial Services Group Inc.Sold 800 shares on 3/22/2024Ownership: 0.044%Michael GreinerSold 8,000 sharesTotal: $152,960.00 ($19.12/share)Vanguard Group Inc.Sold 56,456 shares on 3/11/2024Ownership: 11.727%Julie Ann ShimerBought 500 shares on 3/11/2024Total: $9,925.00 ($19.85/share)View All Insider TransactionsView All Institutional Transactions AVNS Stock Analysis - Frequently Asked Questions Should I buy or sell Avanos Medical stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AVNS shares. View AVNS analyst ratings or view top-rated stocks. What is Avanos Medical's stock price target for 2024? 2 equities research analysts have issued 12-month price objectives for Avanos Medical's shares. Their AVNS share price targets range from $31.00 to $31.00. On average, they expect the company's stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 55.7% from the stock's current price. View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts. How have AVNS shares performed in 2024? Avanos Medical's stock was trading at $22.43 on January 1st, 2024. Since then, AVNS stock has decreased by 11.2% and is now trading at $19.91. View the best growth stocks for 2024 here. Are investors shorting Avanos Medical? Avanos Medical saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 1,340,000 shares, an increase of 6.3% from the February 29th total of 1,260,000 shares. Based on an average daily volume of 297,300 shares, the short-interest ratio is currently 4.5 days. Currently, 3.0% of the company's shares are sold short. View Avanos Medical's Short Interest. When is Avanos Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our AVNS earnings forecast. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its earnings results on Tuesday, February, 20th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by $0.01. The company had revenue of $173.30 million for the quarter, compared to analysts' expectations of $170.43 million. Avanos Medical had a positive trailing twelve-month return on equity of 4.25% and a negative net margin of 8.76%. The business's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.60 earnings per share. What ETF holds Avanos Medical's stock? Invesco S&P SmallCap Health Care ETF holds 119,434 shares of AVNS stock, representing 1.06% of its portfolio. What guidance has Avanos Medical issued on next quarter's earnings? Avanos Medical issued an update on its FY 2024 earnings guidance on Friday, February, 23rd. The company provided earnings per share guidance of 1.300-1.450 for the period. The company issued revenue guidance of $685.0 million-$705.0 million. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA). Who are Avanos Medical's major shareholders? Avanos Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.67%), Vanguard Group Inc. (11.73%), Dimensional Fund Advisors LP (6.15%), Westwood Holdings Group Inc. (4.63%), Paradice Investment Management LLC (3.56%) and Tributary Capital Management LLC (1.49%). Insiders that own company stock include Julie Ann Shimer, Michael Greiner and Patrick J Oleary. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AVNS) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.